Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03311373 · ClinicalTrials.gov registry record · Phase 1
A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010
A Phase 1 study, sponsored by Pearl Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT03311373 is a Phase 1 study that has completed, run by Pearl Therapeutics. The registered enrollment target is 56 participants.
The verdict
NCT03311373, a Phase 1 study, has completed, sponsored by Pearl Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010
Interventions
- DRUG Regimen A
- DRUG Regimen B
- DRUG Regimen C
- DRUG Regimen D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2017-10-17 |
| Est. Completion | 2017-12-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03311373
The ClinicalTrials.gov registry entry for NCT03311373 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pearl Therapeutics, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Regimen A is the first listed.
NCT03311373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03311373 about?
NCT03311373 is a clinical study titled "A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010". Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010
What is the current status of trial NCT03311373?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2017-10-17. Estimated completion is 2017-12-15.
What interventions are being tested in trial NCT03311373?
The interventions under investigation include: Regimen A (DRUG), Regimen B (DRUG), Regimen C (DRUG), Regimen D (DRUG).
Who is sponsoring clinical trial NCT03311373?
This trial is sponsored by Pearl Therapeutics, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.